BIG NEWS EVERYONE: Dr. Mark Alberts has the solution to the two-decade-long tPA-in-stroke debate. And he only needed to cite two trials! https://www.medscape.com/viewarticle/896543?src=soc_fb_180517_mscpedt_news_mdscp_tpastroke&faf=1 … The answer's been right in front of us the whole time; it's a shame everyone was just too dumb to realize it.pic.twitter.com/Vm7bFSR5vD
-
-
Replying to @MedialApproach
pretty rich history on quick openpayments search... not biased at all :P
1 reply 0 retweets 4 likes -
Replying to @grepmeded @MedialApproach
Yeah Alteplase is made by Genentech which is listed in his disclosures
1 reply 0 retweets 0 likes
Replying to @ellesanto @MedialApproach
“equal to or greater than $250” is a BIT of an understatement...
7:16 PM - 19 May 2018
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.